Literature DB >> 19082494

Modification of gene expression induced by siRNA targeting of estrogen receptor alpha in MCF7 human breast cancer cells.

Y A Luqmani1, A Al Azmi, M Al Bader, G Abraham, M El Zawahri.   

Abstract

To establish a model of endocrine resistant breast cancer that is associated with loss of estrogen receptor (ER), MCF7 cells were transfected with several plasmid constructs intended to produce intracellular double stranded hairpin RNA to be processed into siRNA directed against different regions of the ERalpha mRNA. Stably transformed cells were propagated in long-term culture. One of these lines, designated pII, was selected for further analysis. pII cells exhibited reduced levels of ERalpha mRNA and protein as well as several estrogen-regulated genes assessed by real-time PCR and were unresponsive to addition of estradiol and tamoxifen. Higher levels of ERbeta were measurable as compared with parental MCF7 cells. There was an unexpected decrease in expression in members of the EGFR family in contrast with observations reported for ER-negative tumours or some other established endocrine-independent lines. Microarray gene analysis comparing expression in parental MCF7 with pII cells in both serum-synchronised and non-synchronised conditions highlighted a spectrum of other genes that were expressed at different levels compared to the parental MCF7 cells. Genes showing the greatest change were mostly common between synchronized and unsynchronised cells; GRB7, PSMD7, KRT19, KRT18, AKT1, SYNCRIP, CYB5A and EVL for down-regulated in pII and QDPR, VIM, CD68, CA9, STMN1, CDK2, CTSC for up-regulated in pII cells. Notably, the decreased expression of epithelial keratins 18 and 19 and an increase in vimentin and in a macrophage marker CD68, is suggestive of an epithelial to mesothelial transition. Further characterisation of these cells particularly with respect to the factors controlling their growth may contribute to a better understanding of the behaviour of cells that have become endocrine independent by loss of ER function.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19082494

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  24 in total

1.  Orai3 is an estrogen receptor α-regulated Ca²⁺ channel that promotes tumorigenesis.

Authors:  Rajender K Motiani; Xuexin Zhang; Kelly E Harmon; Rebecca S Keller; Khalid Matrougui; James A Bennett; Mohamed Trebak
Journal:  FASEB J       Date:  2012-09-19       Impact factor: 5.191

2.  Novel genetic markers of breast cancer survival identified by a genome-wide association study.

Authors:  Xiao Ou Shu; Jirong Long; Wei Lu; Chun Li; Wendy Y Chen; Ryan Delahanty; Jiarong Cheng; Hui Cai; Ying Zheng; Jiajun Shi; Kai Gu; Wen-Jing Wang; Peter Kraft; Yu-Tang Gao; Qiuyin Cai; Wei Zheng
Journal:  Cancer Res       Date:  2012-01-09       Impact factor: 12.701

3.  Cytochrome B5 type A alleviates HCC metastasis via regulating STOML2 related autophagy and promoting sensitivity to ruxolitinib.

Authors:  Hongrui Guo; Shuhang Liang; Yan Wang; Shuo Zhou; Dalong Yin; Shugeng Zhang; Jizhou Wang; Dehai Wu; Kun Ma; Yufeng Liu; Linmao Sun; Changyong Ji; Xianying Li; Huanran Zhou; Guangchao Yang; Xinyu Guo; Tianming Cui; Zihao Li; Yao Liu; Jiabei Wang; Lianxin Liu
Journal:  Cell Death Dis       Date:  2022-07-18       Impact factor: 9.685

4.  Fulvestrant regulates epidermal growth factor (EGF) family ligands to activate EGF receptor (EGFR) signaling in breast cancer cells.

Authors:  Xihong Zhang; Michael R Diaz; Douglas Yee
Journal:  Breast Cancer Res Treat       Date:  2013-05-18       Impact factor: 4.872

5.  Autoantibody signatures involving glycolysis and splicesome proteins precede a diagnosis of breast cancer among postmenopausal women.

Authors:  Jon J Ladd; Timothy Chao; Melissa M Johnson; Ji Qiu; Alice Chin; Rebecca Israel; Sharon J Pitteri; Jianning Mao; Mei Wu; Lynn M Amon; Martin McIntosh; Christopher Li; Ross Prentice; Nora Disis; Samir Hanash
Journal:  Cancer Res       Date:  2012-12-26       Impact factor: 12.701

6.  The shaping and functional consequences of the microRNA landscape in breast cancer.

Authors:  Heidi Dvinge; Anna Git; Stefan Gräf; Mali Salmon-Divon; Christina Curtis; Andrea Sottoriva; Yongjun Zhao; Martin Hirst; Javier Armisen; Eric A Miska; Suet-Feung Chin; Elena Provenzano; Gulisa Turashvili; Andrew Green; Ian Ellis; Sam Aparicio; Carlos Caldas
Journal:  Nature       Date:  2013-05-05       Impact factor: 49.962

7.  Molecular mechanisms linking high body mass index to breast cancer etiology in post-menopausal breast tumor and tumor-adjacent tissues.

Authors:  Yujing J Heng; Jun Wang; Thomas U Ahearn; Susan B Brown; Xuehong Zhang; Christine B Ambrosone; Victor Piana de Andrade; Adam M Brufsky; Fergus J Couch; Tari A King; Francesmary Modugno; Celine M Vachon; Natalie C DuPre; Montserrat Garcia-Closas; Melissa A Troester; David J Hunter; A Heather Eliassen; Rulla M Tamimi; Susan E Hankinson; Andrew H Beck
Journal:  Breast Cancer Res Treat       Date:  2018-11-01       Impact factor: 4.872

8.  Estrogen receptor silencing induces epithelial to mesenchymal transition in human breast cancer cells.

Authors:  Sanaa Al Saleh; Fahd Al Mulla; Yunus A Luqmani
Journal:  PLoS One       Date:  2011-06-21       Impact factor: 3.240

9.  Assessment of tracer 99mTc(V)-DMSA uptake as a measure of tumor cell proliferation in vitro.

Authors:  Fatma J Al-Saeedi; Princy M Mathew; Yunus A Luqmani
Journal:  PLoS One       Date:  2013-01-15       Impact factor: 3.240

10.  Differential effect of growth factors on invasion and proliferation of endocrine resistant breast cancer cells.

Authors:  Maitham A Khajah; Sanaa Al Saleh; Princy M Mathew; Yunus A Luqmani
Journal:  PLoS One       Date:  2012-07-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.